Showing results (1-10 of 179) with videos related to
Sort By:
Pageof 18
The New Zealand Medical Journal|April 8, 1992
Treatment of extensively invasive (giant) prolactinomas with bromocriptineS K Grebe, J W Delahunt, C M FeekEuropean Journal of Endocrinology|March 1, 1995
Lack of evidence for pituitary thyrotroph down-regulation after 1 week of oral thyrotrophin-releasing hormone and metoclopramide under conditions of constant peripheral thyroid hormone levelsS K Grebe, J W Delahunt, C M Feek, et al.Clinical Endocrinology|November 28, 1997
Inhaled beclomethasone dipropionate suppresses the hypothalamo-pituitary-adrenal axis in a dose dependent mannerS K Grebe, C M Feek, J A Durham, et al.Clinical Endocrinology|July 17, 1998
A randomized trial of short-term treatment of Graves' disease with high-dose carbimazole plus thyroxine versus low-dose carbimazoleS K Grebe, C M Feek, H C Ford, et al.The Medical Journal of Australia|November 23, 2000
Rationing healthcare in New Zealand: the use of clinical guidelinesC M FeekThe Journal of Clinical Endocrinology and Metabolism|March 1, 1997
Treatment of hypothyroidism with once weekly thyroxineS K Grebe, R R Cooke, H C Ford, et al.The New Zealand Medical Journal|March 13, 1991
Once daily, low dose, short term antithyroid drug treatment of Graves' disease is followed by an unacceptably high relapse rateH C Ford, C M Feek, J W DelahuntJournal of Steroid Biochemistry|May 1, 1989
Adrenalectomy does not influence basal secretion of testosterone in rat in vivoC M Feek, N L Tuzi, C R EdwardsJournal of Steroid Biochemistry|April 1, 1989
The adrenal gland and progesterone stimulates testicular steroidogenesis in the rat in vivoC M Feek, N L Tuzi, C R EdwardsThe New Zealand Medical Journal|June 26, 1991
The management of Graves' disease in New Zealand: results of a national surveyH C Ford, J W Delahunt, C M FeekPageof 18